Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

An overview of cell DNA issues.

J Petricciani¹, J Loewer

¹IABs, Palm Springs, CA, USA.

Developments in Biologicals

|January 5, 2002

Summary

Residual cellular DNA in products poses a theoretical risk for transmitting cancer-causing genetic information or viral genes. However, current evidence suggests this risk is negligible and not measurable in most cases.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Evaluation of cell substrates for the production of biologicals: Revision of WHO recommendations. Report of the WHO Study Group on Cell Substrates for the Production of Biologicals, 22-23 April 2009, Bethesda, USA.

Biologicals : journal of the International Association of Biological Standardization·2009

Same author

WHO Study Group on cell substrates for production of biologicals, Geneva, Switzerland, 11-12 June 2007.

Biologicals : journal of the International Association of Biological Standardization·2008

Same author

Cell substrates: where do we stand after 50 years of discussion?

Developments in biologicals·2006

Same author

Are cancer vaccines really the same as infectious disease vaccines?

Developments in biologicals·2004

Same author

A global view of comparability concepts.

Developments in biologicals·2002

Same author

The next steps in HIV vaccine development.

AIDS research and human retroviruses·1992

Area of Science:

Biotechnology
Molecular Biology
Oncology

Background:

Tumor cells may contain oncogenes or viral genes, raising theoretical concerns about DNA transmission.
Viral nucleic acids are known to infect cells, and tumor DNA can transform cells in vitro.
Viral DNA can infect animals, and specific viral oncogenes (e.g., v-src) have induced tumors in animal models.

Purpose of the Study:

To evaluate the theoretical risk of oncogenesis or viral pathology from residual cellular DNA in products.
To assess the scientific evidence supporting and refuting the potential for DNA transmission to cause cancer or viral disease.

Main Methods:

Review of existing scientific literature and data on DNA transformation and oncogenesis.
Analysis of experimental evidence from cell culture and animal studies.
Examination of human and non-human primate data regarding DNA-related risks.

Main Results:

No convincing evidence demonstrates that tumor cell DNA causes tumors in animal test systems.
Limited primate data indicate a non-measurable level of risk from residual cellular DNA.
Risk estimates for residual cellular DNA suggest levels are generally too low to be measurable.

Conclusions:

The theoretical risk of oncogenic events or viral pathology from residual cellular DNA is considered very low.
Current scientific evidence does not support a measurable risk associated with residual cellular DNA in products.
Further research and risk assessment support the safety of products with minimal residual cellular DNA.

Related Experiment Videos